X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-21-2024-40984.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216963
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-24-2024-24602.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217987
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-31-2023-56013.pdf
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-vasopressin-injection-68101.pdf
https://www.globenewswire.com/news-release/2022/08/18/2501137/0/en/Federal-Circuit-Rules-in-Favor-of-Eagle-Pharmaceuticals-in-Vasopressin-Litigation.html
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/aurobindo-pharma-arm-gets-final-us-fda-nod-for-vasopressin-injection/articleshow/93585769.cms
https://www.businesswire.com/news/home/20220811005562/en/Amneal-launches-4-new-Generic-products-including-Vasopressin-single-dose
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212944
https://www.biospace.com/article/releases/amphastar-receives-fda-approval-for-vasopressin/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211857
https://www.pharmacompass.com/pdf/news/fda-confirms-para-iv-patent-litigation-for-vasopressin-injection-1649312529.pdf
https://www.prnewswire.com/news-releases/endo-announces-launch-of-ready-to-use-vasostrict-vasopressin-injection-usp-in-pre-mix-bottles-301476236.html
https://www.prnewswire.com/news-releases/american-regent-introduces-fda-approved-vasopressin-injection-usp-301474869.html
https://www.biospace.com/article/releases/amphastar-receives-fda-tentative-approval-for-vasopressin/
https://consumer.healthday.com/b-12-21-fda-approves-first-injection-for-hiv-prevention-2656081414.html
https://endpts.com/fda-seeks-ftc-action-after-rejecting-petition-to-block-first-generics-for-decades-old-vasopressin/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211538
https://www.businesswire.com/news/home/20210202005379/en/Eagle-Pharmaceuticals-Receives-Additional-FDA-Questions-Regarding-Vasopressin-Court-Date-Set-for-July-7-2021-in-Vasopressin-Trial
https://www.businesswire.com/news/home/20210201005240/en/Eagle-Pharmaceuticals-Announces-Update-in-Vasopressin-Trial-Trial-Date-Postponed
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-30-2020-1609403374.pdf
https://www.fiercebiotech.com/biotech/roche-culls-key-phase-3-drug-trials-including-a-cancer-med-autism-breakthrough-therapy
https://www.fiercepharma.com/manufacturing/endo-comes-out-top-its-fight-fda-and-bulk-compounder
https://www.raps.org/news-and-articles/news-articles/2019/8/fda-wins-court-case-to-not-put-vasopressin-on-comp
https://www.prnewswire.com/news-releases/endo-announces-fda-decision-not-to-include-vasopressin-on-503b-bulks-list-300805205.html
https://www.pharmacompass.com/pdf/news/vasostrict-vasopressin-par-pharmaceutical-vs-amphastar-pharmaceuticals-1546972495.pdf
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-vasostrict-204485-vasopressin-injection-1535780212.pdf
https://www.raps.org/news-and-articles/news-articles/2018/8/fda-singles-out-three-drug-substances-to-not-be-co?feed=Regulatory-Focus
https://www.pharmacompass.com/pdf/news/vasostrict-vasopressin-athenex-pharma-solutions-v-par-pharmaceutical-inc-1534741804.pdf
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-vasostrict-vasopressin-injection-1524810041.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-25-2018-1524633895.pdf
http://www.reuters.com/article/us-usa-fda-endo-intl/endo-international-units-sue-fda-over-drug-compounding-policy-idUSKBN1CV3JV
http://blogs.fda.gov/fdavoice/index.php/2015/04/reducing-the-number-of-unapproved-drugs-while-working-to-prevent-drug-shortages-a-job-that-calls-for-strong-collaboration-in-fda/
Market Place
Share 
